Skip to search formSkip to main contentSkip to account menu

pamatolol

Known as: (2-(4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)phenyl) ethyl)carbamic acid methyl ester, methyl (4-(2-hydroxy-3-(isopropylamino)propoxy)phenylethyl)carbamate 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Propanolamines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1985
1985
Effects of para-substituted beta-adrenoceptor blocking agents and methyl-substituted phenoxypropanolamine derivatives on maximum upstroke velocity of action potential in guinea-pig papillary muscles
SummaryThe effects of atenolol (2–5 mmol/l), sotalol (1–2 mmol/l) and pamatolol (0.1–1 mmol/l), together with N-tertiary butyl… 
1982
1982
β1 and β2 Stimulatory effects of prenalterol
SummaryPrenalterol, previously characterized as a functionally cardioselective partial β-adrenoceptor agonist, was shown to relax… 
1982
1982
beta 1-and beta 2-adrenoceptor stimulatory effects of prenalterol.
Prenalterol, previously characterized as a functionally cardioselective partial beta-adrenoceptor agonist, was shown to relax K… 
1982
1982
Characteristics of the lipolytic beta-adrenergic receptors in hamster adipocytes.
Hamster adipocyte beta-adrenergic receptors were characterized by the effect on the lipolysis rate of several selective beta… 
1979
1979
Kinetics of pamatolol, a cardioselective beta adrenoreceptor blocker
The systemic bioavailability, elimination half‐life (t½), and plasma concentration‐response relationships of pamatolol, a… 
1979
1979
Studies on the metabolism of the beta-adrenoceptor antagonists alprenolol, metoprolol and pamatolol.
Studies on the metabolism of the beta-adrenoceptor antagonists alprenolol, metoprolol and pamatolol 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)